Dizal Pharmaceuticals
Clinical trials sponsored by Dizal Pharmaceuticals, explained in plain language.
-
New pill could outperform chemo for rare lung cancer
Disease control OngoingThis phase 3 trial tests a new oral drug called sunvozertinib (DZD9008) against standard chemotherapy in 324 people with advanced non-small cell lung cancer that has a specific EGFR mutation (exon20 insertion). Participants are randomly assigned to receive either the new drug or …
Phase: PHASE3 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New pill shows promise against tough lung cancer
Disease control OngoingThis study tests a new daily pill, sunvozertinib (DZD9008), in people with advanced non-small cell lung cancer that has certain genetic mutations (EGFR or HER2) and has worsened after prior treatments. The trial aims to find safe doses and see if the drug can shrink tumors. About…
Phase: PHASE1, PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC